Hepatitis A vaccine

Title: Requirements for hepatitis A vaccines (inactivated); Adopted 1994, TRS No 858, Annex 2

Hepatitis B vaccines, DNA recombinant

Recommendations to Assure the Quality, Safety and Efficacy of Recombinant Hepatitis B Vaccines. Proposed replacement of: TRS 786, Annex 2 and TRS 889, Annex 4.

Hepatitis B vaccine, plasma

Hepatitis WHO Working Group on Hepatitis and HIV Diagnostic Kits

Expert Committee on Biological Standardization, Geneva, 17-21 November 2003


  • WHO Working Group meeting on the development of guidelines on labelling influenza vaccines intended to be used for pregnant women, WHO HQ, Geneva, Switzerland, 24-25 September 2015
  • Expert Committee on biological Standardization, WHO HQ, Geneva, Switzerland, 12-16 October 2015
  • WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines, Chiang Mai, Thailand, 18-20 November 2015


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971